<VariationArchive RecordType="classified" VariationID="1192531" VariationName="NM_022098.4(XPNPEP3):c.720dup (p.Gln241fs)" VariationType="Duplication" Accession="VCV001192531" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-08-13" MostRecentSubmission="2021-08-13">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1182536" VariationID="1192531">
      <GeneList>
        <Gene Symbol="XPNPEP3" FullName="X-prolyl aminopeptidase 3" GeneID="63929" HGNC_ID="HGNC:28052" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="40857148" stop="40932815" display_start="40857148" display_stop="40932815" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="41253084" stop="41328822" display_start="41253084" display_stop="41328822" Strand="+" />
          </Location>
          <OMIM>613553</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_022098.4(XPNPEP3):c.720dup (p.Gln241fs)</Name>
      <CanonicalSPDI>NC_000022.11:40886442:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>22q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="40886442" stop="40886443" display_start="40886442" display_stop="40886443" variantLength="1" positionVCF="40886442" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="41282446" stop="41282447" display_start="41282446" display_stop="41282447" variantLength="1" positionVCF="41282446" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>Q241fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028221.1" sequenceAccession="NG_028221" sequenceVersion="1" change="g.34363dup">
            <Expression>NG_028221.1:g.34363dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022098.4" sequenceAccession="NM_022098" sequenceVersion="4" change="c.720dup" MANESelect="true">
            <Expression>NM_022098.4:c.720dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_071381.1" sequenceAccession="NP_071381" sequenceVersion="1" change="p.Gln241fs">
            <Expression>NP_071381.1:p.Gln241fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.41282447dup" Assembly="GRCh37">
            <Expression>NC_000022.10:g.41282447dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.40886443dup" Assembly="GRCh38">
            <Expression>NC_000022.11:g.40886443dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613553.0003" DB="OMIM" />
        <XRef Type="rs" ID="2146254238" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_022098.4(XPNPEP3):c.720dup (p.Gln241fs) AND Nephronophthisis-like nephropathy 1" Accession="RCV001554332" Version="1">
        <ClassifiedConditionList TraitSetID="26">
          <ClassifiedCondition DB="MedGen" ID="C3150419">Nephronophthisis-like nephropathy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-08-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-09" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-08-13" MostRecentSubmission="2021-08-13">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">32660933</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="26" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9598" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis-like nephropathy 1</ElementValue>
                <XRef ID="Nephronophthisis-like+nephropathy+1/8986" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013163" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHPL1</ElementValue>
                <XRef Type="MIM" ID="613159" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18180" />
                <XRef ID="18180" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C3150419" DB="MedGen" />
              <XRef ID="MONDO:0013163" DB="MONDO" />
              <XRef Type="MIM" ID="613159" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3489666" SubmissionDate="2021-08-09" DateLastUpdated="2021-08-13" DateCreated="2021-08-13">
        <ClinVarSubmissionID localKey="613553.0003_NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1" title="XPNPEP3, 1-BP INS, 719A_NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1" />
        <ClinVarAccession Accession="SCV001775564" DateUpdated="2021-08-13" DateCreated="2021-08-13" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-09">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 13-year-old girl, born of consanguineous Iranian parents, with nephronophthisis-like nephropathy-1 (NPHPL1; 613159), Alizadeh et al. (2020) identified a homozygous 1-bp insertion (c.719_720insA, NM_022098.2) in exon 4 of the XPNPEP3 gene, resulting in a frameshift and premature termination (Gln241ThrfsTer13). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. It was not present in public databases, including gnomAD. Functional studies of the variant were not performed, but it was predicted to elicit nonsense-mediated mRNA, resulting in a loss of function. She presented with chronic kidney disease at 3 years of age. Follow-up clinical data was not reported.</Attribute>
              <Citation>
                <ID Source="PubMed">32660933</ID>
              </Citation>
              <XRef DB="OMIM" ID="613159" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XPNPEP3" />
          </GeneList>
          <Name>XPNPEP3, 1-BP INS, 719A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 719A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613553.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3489666" TraitType="Disease" MappingType="Name" MappingValue="NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1" MappingRef="Preferred">
        <MedGen CUI="C3150419" Name="Nephronophthisis-like nephropathy 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

